Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AstraZeneca plc (ADR) - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
AZN
Nasdaq
2834
https://www.astrazeneca.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AstraZeneca plc (ADR)
AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- Apr 25th, 2024 12:00 pm
AstraZeneca, Sanofi Jump On First-Quarter Earnings; Bristol Myers Lags
- Apr 25th, 2024 11:31 am
Trending tickers: Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's
- Apr 25th, 2024 9:56 am
AstraZeneca Earnings, Sales Rise, Beat Forecasts
- Apr 25th, 2024 9:29 am
UPDATE 2-AstraZeneca trounces first-quarter estimates as resilient demand fuels growth
- Apr 25th, 2024 6:10 am
AstraZeneca leaps after smashing first-quarter forecasts
- Apr 25th, 2024 6:06 am
Q1 2024 results
- Apr 25th, 2024 6:00 am
Alphabet, Microsoft, Southwest earnings: What to watch
- Apr 24th, 2024 9:50 pm
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
- Apr 23rd, 2024 1:58 pm
With 85% ownership, AstraZeneca PLC (LON:AZN) boasts of strong institutional backing
- Apr 22nd, 2024 1:27 pm
Insights Into Astrazeneca (AZN) Q1: Wall Street Projections for Key Metrics
- Apr 22nd, 2024 1:16 pm
11 Best Low Price Pharma Stocks To Invest In
- Apr 21st, 2024 2:39 pm
20 Countries with the Highest Cancer Survival Rates in the World
- Apr 19th, 2024 6:05 pm
3 Blue-Chip Stocks to Buy as High Inflation Persists
- Apr 19th, 2024 10:10 am
Astrazeneca (AZN) Could Be a Great Choice
- Apr 18th, 2024 3:45 pm
IMFINZI® (durvalumab) plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase III trial
- Apr 16th, 2024 11:00 am
3 Pharma Stocks That Are Money-Printing Machines in 2024
- Apr 15th, 2024 9:51 pm
4 Exceptional Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
- Apr 14th, 2024 8:41 am
AstraZeneca's (AZN) Fasenra Gets FDA Nod for Asthma in Kids
- Apr 12th, 2024 2:33 pm
Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News
- Apr 12th, 2024 1:22 pm
Scroll